Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas

Show full item record



Permalink

http://hdl.handle.net/10138/318662

Citation

Heby , M , Karnevi , E , Elebro , J , Nodin , B , Eberhard , J , Saukkonen , K , Hagström , J , Mustonen , H , Seppänen , H , Haglund , C , Jirstrom , K & Larsson , A H 2020 , ' Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas ' , Scientific Reports , vol. 10 , no. 1 , 10373 . https://doi.org/10.1038/s41598-020-67187-z

Title: Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
Author: Heby, Margareta; Karnevi, Emelie; Elebro, Jacob; Nodin, Björn; Eberhard, Jakob; Saukkonen, Kapo; Hagström, Jaana; Mustonen, Harri; Seppänen, Hanna; Haglund, Caj; Jirstrom, Karin; Larsson, Anna H.
Contributor: University of Helsinki, Faculty of Medicine
University of Helsinki, Medicum
University of Helsinki, HUS Abdominal Center
University of Helsinki, HUS Abdominal Center
University of Helsinki, HUS Abdominal Center
Date: 2020-06-25
Language: eng
Number of pages: 10
Belongs to series: Scientific Reports
ISSN: 2045-2322
URI: http://hdl.handle.net/10138/318662
Abstract: The outcome of periampullary adenocarcinomas remains poor with few treatment options. Podocalyxin-like protein (PODXL) is an anti-adhesive protein, the high expression of which has been shown to confer a poor prognosis in numerous malignancies. A correlation and adverse prognostic synergy between PODXL and the epidermal growth factor receptor (EGFR) has been observed in colorectal cancer. Here, we investigated whether this also applies to periampullary adenocarcinomas. We analyzed the immunohistochemical expression of PODXL and EGFR in tissue microarrays with tumors from two patient cohorts; (Cohort 1, n=175) and (Cohort 2, n=189). The effect of TGF-beta -induced expression and siRNA-mediated knockdown of PODXL and EGFR, were investigated in pancreatic cancer cells (PANC-1) in vitro. We found a correlation between PODXL and EGFR in these cancers, and a synergistic adverse effect on survival. Furthermore, silencing PODXL in pancreatic cancer cells resulted in the down-regulation of EGFR, but not vice versa. Consequently, these findings suggest a functional link between PODXL and EGFR, and the potential combined utility as biomarkers possibly improving patient stratification. Further studies examining the mechanistic basis underlying these observations may open new avenues of targeted treatment options for subsets of patients affected by these particularly aggressive cancers.
Subject: EPITHELIAL-MESENCHYMAL TRANSITION
POOR-PROGNOSIS
TGF-BETA
MAJOR SIALOPROTEIN
INDEPENDENT FACTOR
CANCER
OVEREXPRESSION
CELLS
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s41598_020_67187_z.pdf 1.843Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record